First human doses of experimental pill tested for safety
NCT ID NCT06673667
Summary
This was the first study to give the experimental oral drug KT-621 to people. Its main goal was to check if the drug is safe and how the body absorbs and processes it. The study involved 118 healthy adult volunteers who received either the drug or a placebo. Researchers measured side effects and how the drug moved through the body at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion
Phoenix, Arizona, 85283, United States
-
Celerion
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.